CADA—computer-aided DaTSCAN analysis
暂无分享,去创建一个
Aldo Quattrone | Maria Eugenia Caligiuri | Andrea Cherubini | Giuseppe Lucio Cascini | Antonio Augimeri | Gennarina Arabia | Domenico Galea | Gaetano Barbagallo | A. Cherubini | A. Quattrone | G. Arabia | M. Caligiuri | G. Barbagallo | G. Cascini | D. Galea | A. Augimeri | Gaetano Barbagallo
[1] Perry E Radau,et al. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] Christopher G. Goetz Chairperson,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004 .
[3] Claus Svarer,et al. MRI-Guided Region-of-Interest Delineation Is Comparable to Manual Delineation in Dopamine Transporter SPECT Quantification in Patients: A Reproducibility Study , 2010, Journal of Nuclear Medicine Technology.
[4] H. Kung,et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT 1 , 1996, European Journal of Nuclear Medicine.
[5] Juan Manuel Górriz,et al. Bilateral symmetry aspects in computer-aided Alzheimer's disease diagnosis by single-photon emission-computed tomography imaging , 2012, Artif. Intell. Medicine.
[6] I G McKeith,et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.
[7] Javier Ramírez,et al. Linear intensity normalization of FP-CIT SPECT brain images using the α-stable distribution , 2013, NeuroImage.
[8] F Segovia,et al. Improved Parkinsonism diagnosis using a partial least squares based approach. , 2012, Medical physics.
[9] Roongroj Bhidayasiri. How useful is (123I) beta-CIT SPECT in the diagnosis of Parkinson's disease? , 2006, Reviews in neurological diseases.
[10] Zoe Katsarou,et al. [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor]. , 2005, Hellenic journal of nuclear medicine.
[11] M. A. Balafar,et al. Gaussian mixture model based segmentation methods for brain MRI images , 2012, Artificial Intelligence Review.
[12] Andrea Skanjeti,et al. Multicenter Semiquantitative Evaluation of 123I‐FP‐CIT Brain SPECT , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[13] F J Martinez-Murcia,et al. Parametrization of textural patterns in 123I-ioflupane imaging for the automatic detection of Parkinsonism. , 2014, Medical physics.
[14] J. Jankovic,et al. Essential tremor and parkinson's disease , 1989, Annals of neurology.
[15] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[16] Donald Grosset,et al. Role of dopamine transporter imaging in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.
[17] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[18] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[19] Kimihiko Abe,et al. New semiquantitative assessment of123I-FP-CIT by an anatomical standardization method , 2006, Annals of Nuclear Medicine.
[20] Peter C. Meltzer,et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1 , 2004, European Journal of Nuclear Medicine.
[21] Piero Calvini,et al. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Koen Van Laere,et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Susanne Klutmann,et al. Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[24] Pablo Aguiar,et al. Validation of semi-quantitative methods for DAT SPECT: influence of anatomical variability and partial volume effect , 2015, Physics in medicine and biology.
[25] S. Asenbaum,et al. [123I]β-CIT and SPECT in essential tremor and Parkinson's disease , 1998, Journal of Neural Transmission.
[26] W. Pirker,et al. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[27] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[28] Rene Donner,et al. Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer) , 2010, Annals of nuclear medicine.
[29] R. Okafor. Maximum likelihood estimation from incomplete data , 1987 .
[30] John S. Fleming,et al. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[31] Stephen M. Smith,et al. A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..
[32] Nikolaos Karatzas,et al. SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[33] Perry E. Radau,et al. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[34] D J Wyper,et al. Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake , 2000, Movement disorders : official journal of the Movement Disorder Society.
[35] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.
[36] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[37] M. Kaufman,et al. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.
[38] John Seibyl,et al. SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.
[39] M Laruelle,et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] Hong Zhang,et al. SPECT Molecular Imaging in Parkinson's Disease , 2012, Journal of biomedicine & biotechnology.